Combining mTORC2 and Src inhibitors synergistically suppresses tumor growth, indicating a potential targeted therapy for malignancies overexpressing IGF2BP1.[110] In addition, phosphorylation of hnRNP A0 significantly influences its role in promoting mitosis via the RAB3GAP1‐ZWINT1 cascade in colorectal cancer cells. Here, HNRNPA0 is linked to neoplasm.